Midatech Pharma anno
Midatech Pharma announces positive pharmacokinetic data with Q-Octreotide
April 26, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 26, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH; Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products in...
Midatech achieves po
Midatech achieves positive dosing data for OpsiSporin Uveitis programme
April 21, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 21, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
Midatech Pharma PLC 
Midatech Pharma PLC (“Midatech” or the “Company”) Audited financial results for the year ended 31 December 2015
April 13, 2016 02:00 ET | Midatech Pharma PLC
Midatech will host a conference call and live Q&A session today (Wednesday 13 April 2016) at 1300 BST / 0800 EDT for analysts and investors to discuss the Annual Results. Dr Jim Phillips, Chief...
Midatech’s Commercia
Midatech’s Commercial Launch of Zuplenz® (Ondansetron) Oral Soluble Film to Prevent Post-Operative, Chemotherapy and Radiation-Induced Nausea and Vomiting in US
April 11, 2016 02:00 ET | Midatech Pharma PLC
ABINGDON, England, April 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH); (Nasdaq:MTP), the international specialty pharmaceutical company focused on commercialising and developing...
PharmaCyte Biotech A
PharmaCyte Biotech Aims for Consolidated Therapy to Address Unmet Medical Need in Upcoming Cancer Clinical Trial
October 15, 2015 09:25 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - October 15, 2015) - PharmaCyte Biotech’s (OTCQB: PMCB) advanced pancreatic cancer treatment of Cell-in-a-Box® capsules + low-doses of ifosfamide has outperformed Eli...
Inform Genomics logo
Inform Genomics Files Provisional Patent Application with United States Patent and Trademark Office (USPTO) -"Systems and Methods for Predicting Treatment-Regimen-Related Outcomes."
October 05, 2015 08:00 ET | Inform Genomics
Boston, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced...
PharmaCyte Biotech's
PharmaCyte Biotech's "Factory" of Live Cells Takes Direct Aim at Cancer Tumors Armed With FDA Orphan Drug Status
March 18, 2015 09:00 ET | PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - March 18, 2015) - PharmaCyte Biotech (OTCQB: PMCB) is aiming directly at the problem patients with advanced pancreatic cancer face, an inoperable tumor! PharmaCyte owns...
Enterade USA
Enterade USA Appoints Stephen J. Gatto Chief Executive Officer
August 26, 2014 09:00 ET | Enterade
NEWBERRY, Fla. and BOSTON, Aug. 26, 2014 (GLOBE NEWSWIRE) -- Enterade USA, LLC, an innovative health sciences company, announced today the appointment of Stephen J. Gatto as its Chairman and Chief...
Inform Genomics logo
Inform Genomics Announces Appointment of Carl de Moor, PhD, as Chief Technology Officer
July 28, 2014 08:00 ET | Inform Genomics
Boston, MA, July 28, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc, a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine...
Five Things You Didn
Five Things You Didn't Know About Chemotherapy
June 24, 2014 11:12 ET | Colon Cancer Alliance
WASHINGTON, D.C., June 24, 2014 (GLOBE NEWSWIRE) -- Cancer. Chemotherapy. Infusion. What image just popped into your mind? Maybe a child in a hospital bed, receiving his medicine through a port in his...